
NYSE:STZ
This summary was created by AI, based on 2 opinions in the last 12 months.
Constellation Brands Inc. has garnered mixed reviews as it approaches its reporting date. One expert expresses confidence in the new CEO and anticipates a potential rebound in beer and cocktail sales, suggesting a positive outlook for the company's future. Conversely, another expert highlights current challenges faced by the alcohol sector, including declining popularity and negative impacts attributed to external factors like ICE raids. This expert notes a significant -36% drop in the stock's value this year and mentions that the stock is trading at a low 12x price-to-earnings ratio. However, this low PE is deemed warranted due to weakening sales trends and increasing competition from GLP-1 drugs. Overall, the outlook suggests uncertainty driven by external pressures and internal adjustments within the company.
(A Top Pick Feb 24/16. Up 25%.) Switched out of this given that it was a consumer staples name, and into more of the cyclical areas. He still likes the name. Trading at 21X forward earnings with a 17% long-term growth rate. Sales going forward could be challenged by Pres. Trump’s potential policy to raise tariffs on Mexican imports.
This has a number of things in its favour right now. Technically it is in a distinct upward trend, outperforming the market with positive momentum, so the technicals are good. Seasonality is more important, because on a seasonal basis it historically reaches a very important low right around the middle of October, and moves higher right through until the middle of February.
This has had tremendous price momentum. It is really a consolidator of wineries and alcoholic beverages. Valuation is OK. Good ROE’s, a little expensive on EB to EBITDA and Price to Free Cash Flow. They have a decent balance sheet, so can continue their strategy of rolling up smaller competitors. Dividend yield of 1%. Not super cheap.